NeoGenomics (NEO) Tops Q3 EPS by 1c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $187.8 million versus the consensus estimate of $183.74 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Fortitude and HeartSciences agree to all-stock merger deal
• CLSA Starts Vedanta Aluminium Metal (VAML:IN) at Outperform (2)